Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Temozolomide × Clear all

Sponsor

Conditions

Glioblastoma 114 Brain Neoplasms 53 Gliosarcoma 52 Glioma 47 Central Nervous System Neoplasms 30 Astrocytoma 29 Melanoma 26 Oligodendroglioma 14 Neuroblastoma 10 Neoplasm Metastasis 9 Recurrence 7 Ependymoma 7 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Sarcoma, Ewing 5 Sarcoma 5 Lymphoma 5 Breast Neoplasms 5 Spinal Cord Neoplasms 4 Somatostatinoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Medulloblastoma 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Lung Neoplasms 3 Gastrinoma 3 Carcinoma, Islet Cell 3 Uveal Melanoma 2 Rhabdomyosarcoma 2

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 13 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡